लोड हो रहा है...
Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
The approval of one of the first anti-vascular endothelial growth factor (VEGF) agents for the treatment of neovascular age-related macular degeneration one decade ago marked the beginning of a new era in the management of several sight-threatening retinal diseases. Since then, emerging evidence has...
में बचाया:
| में प्रकाशित: | Adv Ther |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Springer Healthcare
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5331081/ https://ncbi.nlm.nih.gov/pubmed/28000166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0461-z |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|